{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:07:33Z","timestamp":1790521653379,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00381-019-04363-1","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T16:31:09Z","timestamp":1567787469000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs"],"prefix":"10.1007","volume":"36","author":[{"given":"Julian S.","family":"Rechberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9470-5890","authenticated-orcid":false,"given":"Victor M.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"4363_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1634\/theoncologist.9-2-197","volume":"9","author":"A Broniscer","year":"2004","unstructured":"Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197\u2013206","journal-title":"Oncologist"},{"key":"4363_CR2","unstructured":"Burzynski Research Institute (1996) Antineoplaston Therapy in Treating Patients With Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00003459\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR3","unstructured":"Burzynski Research Institute (2019) Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT02887040\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR4","unstructured":"Burzynski Research Institute (2020) Effect of Antineoplaston Therapy on the QT\/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT02864888\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR5","unstructured":"Cancer Cs, Leukaemia Group (1999) Radiation Therapy And Tamoxifen In Treating Children With Newly Diagnosed Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00024336\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR6","unstructured":"Cancer Cs, Leukaemia Group (2005) Erlotinib Alone Or In Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00360854\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR7","unstructured":"Cancer Cs, Leukaemia Group (2008) Temozolomide And Radiation Therapy in Treating Young Patients With Pontine Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00514397\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR8","unstructured":"Children\u2019s Cancer Hospital Egypt 57357 (2010) Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01635140\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR9","unstructured":"Children\u2019s Cancer Hospital Egypt 57357 (2013) Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01878266\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","volume":"19","author":"KJ Cohen","year":"2017","unstructured":"Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro-Oncology 19:1025\u20131034. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nox021","journal-title":"Neuro-Oncology"},{"key":"4363_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/COC.0b013e318201a2b7","volume":"35","author":"HP Fontanilla","year":"2012","unstructured":"Fontanilla HP, Pinnix CC, Ketonen LM, Woo SY, Vats TS, Rytting ME, Wolff JE, Mahajan A (2012) Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol 35:51\u201357. \nhttps:\/\/doi.org\/10.1097\/COC.0b013e318201a2b7","journal-title":"Am J Clin Oncol"},{"key":"4363_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3171\/2008.11.peds08281","volume":"3","author":"JL Frazier","year":"2009","unstructured":"Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3:259\u2013269. \nhttps:\/\/doi.org\/10.3171\/2008.11.peds08281","journal-title":"J Neurosurg Pediatr"},{"key":"4363_CR13","unstructured":"G\u00f6ttingen Uo, Kinderkrebsstiftung D, Hannover Clinical Trial Center GmbH (2018) International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013). \nhttps:\/\/ClinicalTrials.gov\/show\/NCT03243461\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11910-013-0346-3","volume":"13","author":"SA Grimm","year":"2013","unstructured":"Grimm SA, Chamberlain MC (2013) Brainstem glioma: a review. Curr Neurol Neurosci Rep 13:346. \nhttps:\/\/doi.org\/10.1007\/s11910-013-0346-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4363_CR15","unstructured":"Hoffmann-La Roche (2007) A Study of Capecitabine (Xeloda\u00ae) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01118377\n\n. Accessed 3 Aug 2019"},{"issue":"7","key":"4363_CR16","doi-asserted-by":"publisher","first-page":"e68409","DOI":"10.1371\/journal.pone.0068409","volume":"8","author":"Vojtech Huser","year":"2013","unstructured":"Huser V, Cimino JJ (2013) Linking \nClinicalTrials.gov\n\n and PubMed to track results of interventional human clinical trials. PLoS One 8:e68409. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0068409","journal-title":"PLoS ONE"},{"key":"4363_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00381-003-0870-6","volume":"20","author":"GI Jallo","year":"2004","unstructured":"Jallo GI, Biser-Rohrbaugh A, Freed D (2004) Brainstem gliomas. Childs Nerv Syst 20:143\u2013153. \nhttps:\/\/doi.org\/10.1007\/s00381-003-0870-6","journal-title":"Childs Nerv Syst"},{"key":"4363_CR18","doi-asserted-by":"publisher","first-page":"e26988","DOI":"10.1002\/pbc.26988","volume":"65","author":"A Lassaletta","year":"2018","unstructured":"Lassaletta A, Strother D, Laperriere N, Hukin J, Vanan MI, Goddard K, Lafay-Cousin L, Johnston DL, Zelcer S, Zapotocky M, Rajagopal R, Ramaswamy V, Hawkins C, Tabori U, Huang A, Bartels U, Bouffet E (2018) Reirradiation in patients with diffuse intrinsic pontine gliomas: the Canadian experience. Pediatr Blood Cancer 65:e26988. \nhttps:\/\/doi.org\/10.1002\/pbc.26988","journal-title":"Pediatr Blood Cancer"},{"key":"4363_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1148\/radiol.12111976","volume":"264","author":"KJ Lim","year":"2012","unstructured":"Lim KJ, Yoon DY, Yun EJ, Seo YL, Baek S, Gu DH, Yoon SJ, Han A, Ku YJ, Kim SS (2012) Characteristics and trends of radiology research: a survey of original articles published in AJR and radiology between 2001 and 2010. Radiology 264:796\u2013802. \nhttps:\/\/doi.org\/10.1148\/radiol.12111976","journal-title":"Radiology"},{"key":"4363_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fonc.2015.00148","volume":"5","author":"A Morales La Madrid","year":"2015","unstructured":"Morales La Madrid A, Hashizume R, Kieran MW (2015) Future clinical trials in DIPG: bringing epigenetics to the clinic. Front Oncol 5:148. \nhttps:\/\/doi.org\/10.3389\/fonc.2015.00148","journal-title":"Front Oncol"},{"key":"4363_CR21","unstructured":"National Cancer Institute (1998) Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00003625"},{"key":"4363_CR22","unstructured":"National Cancer Institute (1999) Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00003935"},{"key":"4363_CR23","unstructured":"National Cancer Institute (2001) Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Or Recurrent Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00021229"},{"key":"4363_CR24","unstructured":"National Cancer Institute (2001) Radiation Therapy Plus Carboplatin And Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00005602"},{"key":"4363_CR25","unstructured":"National Cancer Institute (2002) Chemotherapy And Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00028795"},{"key":"4363_CR26","unstructured":"National Cancer Institute (2002) Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00042991"},{"key":"4363_CR27","unstructured":"National Cancer Institute (2003) Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00070525"},{"key":"4363_CR28","unstructured":"National Cancer Institute (2004) Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00079339"},{"key":"4363_CR29","unstructured":"National Cancer Institute (2005) Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00107471"},{"key":"4363_CR30","unstructured":"National Cancer Institute (2006) Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, Or Refractory Glioma, Medulloblastoma, Ependymoma, Or Low Grade Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00381797"},{"key":"4363_CR31","unstructured":"National Cancer Institute (2006) O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00275002\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR32","unstructured":"National Cancer Institute (2007) Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00387790\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR33","unstructured":"National Cancer Institute (2010) Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01189266\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR34","unstructured":"National Cancer Institute (2010) Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01236560\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR35","unstructured":"National Cancer Institute (2013) Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01922076\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR36","unstructured":"National Cancer Institute (2015) Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT02359565\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR37","unstructured":"National Cancer Institute (2015) Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT02415153\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR38","unstructured":"National Cancer Institute (2018) Phase I Study of APX005M in Pediatric CNS Tumors. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT03389802\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR39","unstructured":"National Institutes of Health Clinical Center (2002) A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT00036569\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR40","unstructured":"Pdq Integrative A, Complementary Therapies Editorial B (2002) Antineoplastons (PDQ(R)): Health Professional Version. In: PDQ cancer information summaries. National Cancer Institute (US), Bethesda (MD)"},{"issue":"10","key":"4363_CR41","doi-asserted-by":"publisher","first-page":"e111055","DOI":"10.1371\/journal.pone.0111055","volume":"9","author":"Pascal B. Pfiffner","year":"2014","unstructured":"Pfiffner PB, Oh J, Miller TA, Mandl KD (2014) \nClinicalTrials.gov\n\n as a data source for semi-automated point-of-care trial eligibility screening. PLoS One 9:e111055. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0111055","journal-title":"PLoS ONE"},{"key":"4363_CR42","unstructured":"Phoenix Children\u2019s Hospital (2013) Erivedge (vismodegib) in the treatment of pediatric patients with refractory pontine glioma. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT01774253\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/2018.10.peds18377","volume":"23","author":"IF Pollack","year":"2019","unstructured":"Pollack IF, Agnihotri S, Broniscer A (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23:261\u2013273. \nhttps:\/\/doi.org\/10.3171\/2018.10.peds18377","journal-title":"J Neurosurg Pediatr"},{"key":"4363_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jager N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Fruhwald MC, Roggendorf W, Kramm C, Durken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226\u2013231. \nhttps:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"4363_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10143-012-0428-8","volume":"36","author":"T Sun","year":"2013","unstructured":"Sun T, Wan W, Wu Z, Zhang J, Zhang L (2013) Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups. Neurosurg Rev 36:311\u2013319; discussion 319-320. \nhttps:\/\/doi.org\/10.1007\/s10143-012-0428-8","journal-title":"Neurosurg Rev"},{"key":"4363_CR46","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cncr.20096","volume":"100","author":"AA Tzika","year":"2004","unstructured":"Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM (2004) Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Cancer 100:1246\u20131256. \nhttps:\/\/doi.org\/10.1002\/cncr.20096","journal-title":"Cancer"},{"key":"4363_CR47","unstructured":"University of California SF, Research TVFfC, Consortium PPN-O (2016) H3.3K27M peptide vaccine for children with newly diagnosed dipg and other gliomas. \nhttps:\/\/ClinicalTrials.gov\/show\/NCT02960230\n\n. Accessed 3 Aug 2019"},{"key":"4363_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fonc.2015.00237","volume":"5","author":"MI Vanan","year":"2015","unstructured":"Vanan MI, Eisenstat DD (2015) DIPG in children - what can we learn from the past? Front Oncol 5:237. \nhttps:\/\/doi.org\/10.3389\/fonc.2015.00237","journal-title":"Front Oncol"},{"key":"4363_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2:205. \nhttps:\/\/doi.org\/10.3389\/fonc.2012.00205","journal-title":"Front Oncol"},{"key":"4363_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Baker SJ (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253. \nhttps:\/\/doi.org\/10.1038\/ng.1102","journal-title":"Nat Genet"},{"key":"4363_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2176\/nmc.43.375","volume":"43","author":"J Yoshimura","year":"2003","unstructured":"Yoshimura J, Onda K, Tanaka R, Takahashi H (2003) Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir (Tokyo) 43:375\u2013382 discussion 382","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-019-04363-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-019-04363-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-019-04363-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:10:49Z","timestamp":1599261049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-019-04363-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4363"],"URL":"https:\/\/doi.org\/10.1007\/s00381-019-04363-1","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no funding sources or conflict of interest concerning the materials or methods used in this study or the findings specified in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}